ICAM1 and breast cancer: These results indicate that IFN-γ + TNF-α-treatment of BC cell lines improved the binding between NK cells and BC cells through the modulation of the adhesion molecule ICAM-1, thus supporting NK cell-mediated activity against BC cells.